The aberrant CD8+ T cell phenotype seen in CTEPH patients, akin to changes in CCR6, CTLA4 and cytokine expression found in CD4+ T cells, suggests that CD8+ T cells are involved in the pathogenesis of CTEPH as well. The gene discussed is CTLA4; the disease is chronic thromboembolic pulmonary hypertension.